BioSpace News Archive

Deals

Aridis Pharmaceuticals Announces $25 Million Registered Direct Offering Priced at a Premium to Market

Aridis Pharmaceuticals, Inc. today announced that it has entered into a definitive agreement with a single healthcare-focused institutional investor for the purchase and sale of 4,947,556 shares of the Company’s common stock

August 2, 2021
·
7 min read
Biotech Beach

Micronoma Wins Bio-IT World Innovative Practices Award

Micronoma announces that they are the recipient of the Bio-IT World Innovative Practices Award.

August 2, 2021
·
2 min read
Business

ENDRA Life Sciences to Report Second Quarter 2021 Financial Results on August 12, 2021

ENDRA Life Sciences Inc. today announced that the company will report financial results for the second quarter of 2021 on Thursday, August 12, 2021 after the close of trading on the U.S. financial markets.

August 2, 2021
·
1 min read
WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate

WuXi Biologics announced that only 13 months after receiving its first GMP certificate, it has once again received a European Medicines Agency (EMA) GMP certificate for the Biosafety Testing facility in Suzhou.

August 2, 2021
·
3 min read
Business

LianBio Appoints Pascal Qian as General Manager of China

LianBio today announced that it has appointed Pascal Qian to the position of China General Manager.

August 2, 2021
·
2 min read
Drug Development

Hoth Therapeutics Initiates Preclinical Study of HT-ALZ for Alzheimer’s Disease

Hoth Therapeutics, Inc. announced today that it has initiated its preclinical study utilizing Hoth’s HT-ALZ in an animal model.

August 2, 2021
·
4 min read
BioCapital

IZI Medical Products Announces the Launch of Vertefix® HV Cement with Insite™ Tracking Beads

IZI Medical Products announces the official launch of Vertefix HV Cement (“Vertefix HV”). Vertefix HV provides a unique solution that addresses the need for real-time flow visualization during cement injection for vertebroplasty and kyphoplasty procedures.

August 2, 2021
·
2 min read
Business

ChemoCentryx to Hold Second Quarter 2021 Financial Results Conference Call on Monday, August 9, 2021

ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company’s second quarter 2021 financial results will be released after market close on Monday, August 9, 2021.

August 2, 2021
·
1 min read
Pharm Country

Phathom Pharmaceuticals to Participate in the BMO Biopharma Spotlight Series: Innovation in GI

Phathom Pharmaceuticals, Inc. announced today that Terrie Curran, Phathom’s President and Chief Executive Officer, will participate in the “Innovation in GI” panel discussion at the BMO Biopharma Spotlight Series virtual conference on Thursday, August 12, 2021 at 10:50 a.m. ET.

August 2, 2021
·
1 min read
Business

Allogene Therapeutics Appoints Industry Leaders Elizabeth (Liz) Barrett and Vicki Sato, Ph.D., to its Board of Directors

Allogene Therapeutics, Inc. today announced the appointment of Elizabeth (Liz) Barrett and Vicki Sato, Ph.D. to the company’s Board of Directors.

August 2, 2021
·
5 min read